CEACAM5 and colorectal carcinoma: Specifically for CRC, pathological staging directly informs treatment planning, while laboratory indicators—such as carcinoembryonic antigen and inflammatory markers—dynamically reflect disease progression and the patient's systemic condition.[38] Therefore, we integrated the bimodal information from images and tablesto simulate the comprehensive decision‐making logic of clinicians, which is qualitative pathology combined with quantitative indicators.